NEWSLETTER

Pigs As Future Organ Donors, Malaria Tests Made Easy & I’m Co-Author On A Thing (#9)

This Week in Synthetic Biology #9

Niko McCarty
Sep 25 · 6 min read
Image for post
Image for post

🧬Featured Research

During my time at Caltech, I contributed to a study (led by Bill Ireland and Suzy Beeler) that was published in eLife this week. In this study, Bill and Suzy created an experimental tool, called Reg-Seq, that combines massively parallel assays with mass spectrometry to determine the nucleotide-by-nucleotide contribution to DNA binding energy for 100+ promoters. With this method, we can determine where transcription factors (activators and repressors) cling to DNA, and then use this information to design new promoters with predictable expression levels. There is also a suite of online resources that we created, including code, tutorials, and an interactive figure so that you can look at the data for 100+ E. coli promoters yourself.

Xenotransplantation (taking an organ from one animal to give to another) is an ever-present theme in fiction; it appears in writings by Kazuo Ishiguro and Neal Shusterman, for example. A new study, published in Nature Biomedical Engineering, has brought xenotransplantation (from pigs to humans) one tiny step closer to reality. Luhan Yang (co-founder of a xenotransplantation company) and George Church’s group collaborated on the study. The researchers first deactivated all porcine endogenous retroviruses in pigs, which is crucial to prevent cross-species transmission of the virus (which is infectious to humans). Then, they engineered the pigs to express nine human transgenes that “enhance the pigs’ immunological compatibility and blood-coagulation compatibility with humans”. Fiction is one step closer to reality.

The World Health Organization estimates that there were 228 million cases of malaria in 2018. Rapid, easy testing for malaria could go a long way in combatting this global threat (which has likely killed more people than any disease in human history). A new CRISPR-based system, developed by the Collins lab at MIT, can be used to diagnose the “four major pathogenic Plasmodium species”, and it can do it in 60 minutes with an astounding sensitivity. In the case of Plasmodium falciparum, they could detect a single parasite in about three microliters of blood. The study was published in PNAS. Read the Wyss Institute news piece, too.

Artificial cells are lipid spheres, usually packed with some protein and DNA, that can be programmed to carry out a simple task, like glow green or produce a protein from a DNA template. From a historical perspective, artificial cells have been quite simple until recently. Now, new research has taken these protean cells one step further, demonstrating the creation of artificial cells that can chemically communicate with mammalian cells under physiological conditions. Researchers in Trento, Italy and Alberta, Canada created the cells from POPC (a type of phospholipid) and cholesterol and packaged them with DNA templates to synthesize a neurotrophic factor. When these artificial cells sense a specific small molecule in their environment, they switch on their genetic program, synthesize the neurotrophic factor, and “send it” to a neighboring neuron, triggering neuronal differentiation. This study was published in Science Advances.

🧫 Rapid-Fire Highlights

📰 #SynBio in the News

Thanks for reading This Week in Synthetic Biology, part of Bioeconomy.XYZ. If you enjoy this newsletter, please share it with a friend. Reach me with tips and feedback via Twitter direct message at @NikoMcCarty.

Bioeconomy.XYZ

Innovation for the Bioeconomy

Niko McCarty

Written by

Science journalism at NYU. Previously Caltech, Imperial College. #SynBio newsletter: https://synbio.substack.com Web: https://nikomccarty.com

Bioeconomy.XYZ

The Medium publication for biotechnology and everyone involved in the revolution. The best brought to you by the brightest. Founded by @1AlexanderTitus for you.

Niko McCarty

Written by

Science journalism at NYU. Previously Caltech, Imperial College. #SynBio newsletter: https://synbio.substack.com Web: https://nikomccarty.com

Bioeconomy.XYZ

The Medium publication for biotechnology and everyone involved in the revolution. The best brought to you by the brightest. Founded by @1AlexanderTitus for you.

Medium is an open platform where 170 million readers come to find insightful and dynamic thinking. Here, expert and undiscovered voices alike dive into the heart of any topic and bring new ideas to the surface. Learn more

Follow the writers, publications, and topics that matter to you, and you’ll see them on your homepage and in your inbox. Explore

If you have a story to tell, knowledge to share, or a perspective to offer — welcome home. It’s easy and free to post your thinking on any topic. Write on Medium

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store